Found 34 hits of Enzyme Inhibition Constant Data Target/Host
(Institution) | Ligand | Target/Host
Links | Ligand
Links | Trg + Lig
Links | Ki
nM | ΔG°
kJ/mole | IC50
nM | Kd
nM | EC50/IC50
nM | koff
s-1 | kon
M-1s-1 | pH | Temp
°C |
|---|
RAF proto-oncogene serine/threonine-protein kinase
(Homo sapiens (Human)) | BDBM16673
(4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamo...)Show SMILES CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1 Show InChI InChI=1S/C21H16ClF3N4O3/c1-26-19(30)18-11-15(8-9-27-18)32-14-5-2-12(3-6-14)28-20(31)29-13-4-7-17(22)16(10-13)21(23,24)25/h2-11H,1H3,(H,26,30)(H2,28,29,31) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
| Purchase
CHEMBL
DrugBank
MCE
MMDB
PC cid
PC sid
PDB
UniChem
Patents
Similars
| DrugBank
Article
PubMed
| n/a | n/a | 40 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Serono
Curated by ChEMBL
| Assay Description
Inhibition of human cRAF using [gamma-33P-ATP] as a substrate by scintillation counting |
Bioorg Med Chem Lett 21: 2264-9 (2011)
Article DOI: 10.1016/j.bmcl.2011.02.108
BindingDB Entry DOI: 10.7270/Q2MS3T23 |
More data for this
Ligand-Target Pair | |
RAF proto-oncogene serine/threonine-protein kinase
(Homo sapiens (Human)) | BDBM50340266
(7-(2-(3-(4-chloro-2-methoxy-5-(trifluoromethyl)phe...)Show SMILES CNC(=O)c1cc2ccc(CCNC(=O)Nc3cc(c(Cl)cc3OC)C(F)(F)F)cc2cn1 Show InChI InChI=1S/C22H20ClF3N4O3/c1-27-20(31)18-8-13-4-3-12(7-14(13)11-29-18)5-6-28-21(32)30-17-9-15(22(24,25)26)16(23)10-19(17)33-2/h3-4,7-11H,5-6H2,1-2H3,(H,27,31)(H2,28,30,32) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 80 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Serono
Curated by ChEMBL
| Assay Description
Inhibition of human cRAF using [gamma-33P-ATP] as a substrate by scintillation counting |
Bioorg Med Chem Lett 21: 2264-9 (2011)
Article DOI: 10.1016/j.bmcl.2011.02.108
BindingDB Entry DOI: 10.7270/Q2MS3T23 |
More data for this
Ligand-Target Pair | |
RAF proto-oncogene serine/threonine-protein kinase
(Homo sapiens (Human)) | BDBM50340264
(7-(2-(3-(5-chloro-2-methoxy-4-methylphenyl)ureido)...)Show SMILES CNC(=O)c1cc2ccc(CCNC(=O)Nc3cc(Cl)c(C)cc3OC)cc2cn1 Show InChI InChI=1S/C22H23ClN4O3/c1-13-8-20(30-3)18(11-17(13)23)27-22(29)25-7-6-14-4-5-15-10-19(21(28)24-2)26-12-16(15)9-14/h4-5,8-12H,6-7H2,1-3H3,(H,24,28)(H2,25,27,29) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 110 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Serono
Curated by ChEMBL
| Assay Description
Inhibition of human cRAF using [gamma-33P-ATP] as a substrate by scintillation counting |
Bioorg Med Chem Lett 21: 2264-9 (2011)
Article DOI: 10.1016/j.bmcl.2011.02.108
BindingDB Entry DOI: 10.7270/Q2MS3T23 |
More data for this
Ligand-Target Pair | |
RAF proto-oncogene serine/threonine-protein kinase
(Homo sapiens (Human)) | BDBM50340262
(7-(2-(3-(2-methoxy-5-(trifluoromethyl)phenyl)ureid...)Show SMILES CNC(=O)c1cc2ccc(CCNC(=O)Nc3cc(ccc3OC)C(F)(F)F)cc2cn1 Show InChI InChI=1S/C22H21F3N4O3/c1-26-20(30)18-10-14-4-3-13(9-15(14)12-28-18)7-8-27-21(31)29-17-11-16(22(23,24)25)5-6-19(17)32-2/h3-6,9-12H,7-8H2,1-2H3,(H,26,30)(H2,27,29,31) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 120 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Serono
Curated by ChEMBL
| Assay Description
Inhibition of human cRAF using [gamma-33P-ATP] as a substrate by scintillation counting |
Bioorg Med Chem Lett 21: 2264-9 (2011)
Article DOI: 10.1016/j.bmcl.2011.02.108
BindingDB Entry DOI: 10.7270/Q2MS3T23 |
More data for this
Ligand-Target Pair | |
RAF proto-oncogene serine/threonine-protein kinase
(Homo sapiens (Human)) | BDBM50340273
(CHEMBL1760633 | N-(6-(2-(3-(4-chloro-3-(trifluorom...)Show SMILES CC(=O)Nc1nc2ccc(CCNC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2[nH]1 Show InChI InChI=1S/C19H17ClF3N5O2/c1-10(29)25-17-27-15-5-2-11(8-16(15)28-17)6-7-24-18(30)26-12-3-4-14(20)13(9-12)19(21,22)23/h2-5,8-9H,6-7H2,1H3,(H2,24,26,30)(H2,25,27,28,29) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 140 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Serono
Curated by ChEMBL
| Assay Description
Inhibition of human cRAF using [gamma-33P-ATP] as a substrate by scintillation counting |
Bioorg Med Chem Lett 21: 2264-9 (2011)
Article DOI: 10.1016/j.bmcl.2011.02.108
BindingDB Entry DOI: 10.7270/Q2MS3T23 |
More data for this
Ligand-Target Pair | |
RAF proto-oncogene serine/threonine-protein kinase
(Homo sapiens (Human)) | BDBM50340259
(7-(2-(3-(4-chloro-3-(trifluoromethyl)phenyl)ureido...)Show SMILES CNC(=O)c1cc2ccc(CCNC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2cn1 Show InChI InChI=1S/C21H18ClF3N4O2/c1-26-19(30)18-9-13-3-2-12(8-14(13)11-28-18)6-7-27-20(31)29-15-4-5-17(22)16(10-15)21(23,24)25/h2-5,8-11H,6-7H2,1H3,(H,26,30)(H2,27,29,31) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 160 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Serono
Curated by ChEMBL
| Assay Description
Inhibition of human cRAF using [gamma-33P-ATP] as a substrate by scintillation counting |
Bioorg Med Chem Lett 21: 2264-9 (2011)
Article DOI: 10.1016/j.bmcl.2011.02.108
BindingDB Entry DOI: 10.7270/Q2MS3T23 |
More data for this
Ligand-Target Pair | |
RAF proto-oncogene serine/threonine-protein kinase
(Homo sapiens (Human)) | BDBM50340270
(CHEMBL1760630 | N-(6-(2-(3-(2-methoxy-5-(trifluoro...)Show SMILES COc1ccc(cc1NC(=O)NCCc1ccc2nc(NC(C)=O)[nH]c2c1)C(F)(F)F Show InChI InChI=1S/C20H20F3N5O3/c1-11(29)25-18-26-14-5-3-12(9-15(14)27-18)7-8-24-19(30)28-16-10-13(20(21,22)23)4-6-17(16)31-2/h3-6,9-10H,7-8H2,1-2H3,(H2,24,28,30)(H2,25,26,27,29) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 170 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Serono
Curated by ChEMBL
| Assay Description
Inhibition of human cRAF using [gamma-33P-ATP] as a substrate by scintillation counting |
Bioorg Med Chem Lett 21: 2264-9 (2011)
Article DOI: 10.1016/j.bmcl.2011.02.108
BindingDB Entry DOI: 10.7270/Q2MS3T23 |
More data for this
Ligand-Target Pair | |
RAF proto-oncogene serine/threonine-protein kinase
(Homo sapiens (Human)) | BDBM50340285
(CHEMBL1760736 | N-(6-(2-(3-(2-(2-aminoethoxy)-4-ch...)Show SMILES CC(=O)Nc1nc2ccc(CCNC(=O)Nc3cc(c(Cl)cc3OCCN)C(F)(F)F)cc2[nH]1 Show InChI InChI=1S/C21H22ClF3N6O3/c1-11(32)28-19-29-15-3-2-12(8-16(15)30-19)4-6-27-20(33)31-17-9-13(21(23,24)25)14(22)10-18(17)34-7-5-26/h2-3,8-10H,4-7,26H2,1H3,(H2,27,31,33)(H2,28,29,30,32) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 180 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Serono
Curated by ChEMBL
| Assay Description
Inhibition of human cRAF using [gamma-33P-ATP] as a substrate by scintillation counting |
Bioorg Med Chem Lett 21: 2264-9 (2011)
Article DOI: 10.1016/j.bmcl.2011.02.108
BindingDB Entry DOI: 10.7270/Q2MS3T23 |
More data for this
Ligand-Target Pair | |
RAF proto-oncogene serine/threonine-protein kinase
(Homo sapiens (Human)) | BDBM50340265
(7-(2-(3-(4-chloro-2-methoxy-5-methylphenyl)ureido)...)Show SMILES CNC(=O)c1cc2ccc(CCNC(=O)Nc3cc(C)c(Cl)cc3OC)cc2cn1 Show InChI InChI=1S/C22H23ClN4O3/c1-13-8-18(20(30-3)11-17(13)23)27-22(29)25-7-6-14-4-5-15-10-19(21(28)24-2)26-12-16(15)9-14/h4-5,8-12H,6-7H2,1-3H3,(H,24,28)(H2,25,27,29) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 190 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Serono
Curated by ChEMBL
| Assay Description
Inhibition of human cRAF using [gamma-33P-ATP] as a substrate by scintillation counting |
Bioorg Med Chem Lett 21: 2264-9 (2011)
Article DOI: 10.1016/j.bmcl.2011.02.108
BindingDB Entry DOI: 10.7270/Q2MS3T23 |
More data for this
Ligand-Target Pair | |
RAF proto-oncogene serine/threonine-protein kinase
(Homo sapiens (Human)) | BDBM50340277
(CHEMBL1760637 | N-(6-(2-(3-(5-chloro-2-methoxy-4-m...)Show SMILES COc1cc(C)c(Cl)cc1NC(=O)NCCc1ccc2nc(NC(C)=O)[nH]c2c1 Show InChI InChI=1S/C20H22ClN5O3/c1-11-8-18(29-3)17(10-14(11)21)26-20(28)22-7-6-13-4-5-15-16(9-13)25-19(24-15)23-12(2)27/h4-5,8-10H,6-7H2,1-3H3,(H2,22,26,28)(H2,23,24,25,27) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 190 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Serono
Curated by ChEMBL
| Assay Description
Inhibition of human cRAF using [gamma-33P-ATP] as a substrate by scintillation counting |
Bioorg Med Chem Lett 21: 2264-9 (2011)
Article DOI: 10.1016/j.bmcl.2011.02.108
BindingDB Entry DOI: 10.7270/Q2MS3T23 |
More data for this
Ligand-Target Pair | |
RAF proto-oncogene serine/threonine-protein kinase
(Homo sapiens (Human)) | BDBM50340288
(CHEMBL1760617 | N-methyl-7-(2-(3-(3-(trifluorometh...)Show SMILES CNC(=O)c1cc2ccc(CCNC(=O)Nc3cccc(c3)S(=O)(=O)C(F)(F)F)cc2cn1 Show InChI InChI=1S/C21H19F3N4O4S/c1-25-19(29)18-10-14-6-5-13(9-15(14)12-27-18)7-8-26-20(30)28-16-3-2-4-17(11-16)33(31,32)21(22,23)24/h2-6,9-12H,7-8H2,1H3,(H,25,29)(H2,26,28,30) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
| Article
PubMed
| n/a | n/a | 200 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Serono
Curated by ChEMBL
| Assay Description
Inhibition of human cRAF using [gamma-33P-ATP] as a substrate by scintillation counting |
Bioorg Med Chem Lett 21: 2264-9 (2011)
Article DOI: 10.1016/j.bmcl.2011.02.108
BindingDB Entry DOI: 10.7270/Q2MS3T23 |
More data for this
Ligand-Target Pair | |
RAF proto-oncogene serine/threonine-protein kinase
(Homo sapiens (Human)) | BDBM50340258
(CHEMBL1760619 | N-methyl-7-(2-(3-(4-methyl-3-(trif...)Show SMILES CNC(=O)c1cc2ccc(CCNC(=O)Nc3ccc(C)c(c3)C(F)(F)F)cc2cn1 Show InChI InChI=1S/C22H21F3N4O2/c1-13-3-6-17(11-18(13)22(23,24)25)29-21(31)27-8-7-14-4-5-15-10-19(20(30)26-2)28-12-16(15)9-14/h3-6,9-12H,7-8H2,1-2H3,(H,26,30)(H2,27,29,31) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 200 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Serono
Curated by ChEMBL
| Assay Description
Inhibition of human cRAF using [gamma-33P-ATP] as a substrate by scintillation counting |
Bioorg Med Chem Lett 21: 2264-9 (2011)
Article DOI: 10.1016/j.bmcl.2011.02.108
BindingDB Entry DOI: 10.7270/Q2MS3T23 |
More data for this
Ligand-Target Pair | |
RAF proto-oncogene serine/threonine-protein kinase
(Homo sapiens (Human)) | BDBM50340281
(CHEMBL1760641 | N-(6-(2-(3-(2-(2-(methylamino)etho...)Show SMILES CNCCOc1ccc(cc1NC(=O)NCCc1ccc2nc(NC(C)=O)[nH]c2c1)C(F)(F)F Show InChI InChI=1S/C22H25F3N6O3/c1-13(32)28-20-29-16-5-3-14(11-17(16)30-20)7-8-27-21(33)31-18-12-15(22(23,24)25)4-6-19(18)34-10-9-26-2/h3-6,11-12,26H,7-10H2,1-2H3,(H2,27,31,33)(H2,28,29,30,32) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 210 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Serono
Curated by ChEMBL
| Assay Description
Inhibition of human cRAF using [gamma-33P-ATP] as a substrate by scintillation counting |
Bioorg Med Chem Lett 21: 2264-9 (2011)
Article DOI: 10.1016/j.bmcl.2011.02.108
BindingDB Entry DOI: 10.7270/Q2MS3T23 |
More data for this
Ligand-Target Pair | |
RAF proto-oncogene serine/threonine-protein kinase
(Homo sapiens (Human)) | BDBM50340290
(CHEMBL1760737 | N-(6-(2-(3-(2-(pyrrolidin-2-ylmeth...)Show SMILES CC(=O)Nc1nc2ccc(CCNC(=O)Nc3cc(ccc3OCC3CCCN3)C(F)(F)F)cc2[nH]1 Show InChI InChI=1S/C24H27F3N6O3/c1-14(34)30-22-31-18-6-4-15(11-19(18)32-22)8-10-29-23(35)33-20-12-16(24(25,26)27)5-7-21(20)36-13-17-3-2-9-28-17/h4-7,11-12,17,28H,2-3,8-10,13H2,1H3,(H2,29,33,35)(H2,30,31,32,34) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 230 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Serono
Curated by ChEMBL
| Assay Description
Inhibition of human cRAF using [gamma-33P-ATP] as a substrate by scintillation counting |
Bioorg Med Chem Lett 21: 2264-9 (2011)
Article DOI: 10.1016/j.bmcl.2011.02.108
BindingDB Entry DOI: 10.7270/Q2MS3T23 |
More data for this
Ligand-Target Pair | |
RAF proto-oncogene serine/threonine-protein kinase
(Homo sapiens (Human)) | BDBM50340282
(CHEMBL1760642 | N-(6-(2-(3-(4-chloro-2-(2-(methyla...)Show SMILES CNCCOc1cc(Cl)c(cc1NC(=O)NCCc1ccc2nc(NC(C)=O)[nH]c2c1)C(F)(F)F Show InChI InChI=1S/C22H24ClF3N6O3/c1-12(33)29-20-30-16-4-3-13(9-17(16)31-20)5-6-28-21(34)32-18-10-14(22(24,25)26)15(23)11-19(18)35-8-7-27-2/h3-4,9-11,27H,5-8H2,1-2H3,(H2,28,32,34)(H2,29,30,31,33) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 230 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Serono
Curated by ChEMBL
| Assay Description
Inhibition of human cRAF using [gamma-33P-ATP] as a substrate by scintillation counting |
Bioorg Med Chem Lett 21: 2264-9 (2011)
Article DOI: 10.1016/j.bmcl.2011.02.108
BindingDB Entry DOI: 10.7270/Q2MS3T23 |
More data for this
Ligand-Target Pair | |
RAF proto-oncogene serine/threonine-protein kinase
(Homo sapiens (Human)) | BDBM50340260
(7-(2-(3-(4-fluoro-3-(trifluoromethyl)phenyl)ureido...)Show SMILES CNC(=O)c1cc2ccc(CCNC(=O)Nc3ccc(F)c(c3)C(F)(F)F)cc2cn1 Show InChI InChI=1S/C21H18F4N4O2/c1-26-19(30)18-9-13-3-2-12(8-14(13)11-28-18)6-7-27-20(31)29-15-4-5-17(22)16(10-15)21(23,24)25/h2-5,8-11H,6-7H2,1H3,(H,26,30)(H2,27,29,31) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 240 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Serono
Curated by ChEMBL
| Assay Description
Inhibition of human cRAF using [gamma-33P-ATP] as a substrate by scintillation counting |
Bioorg Med Chem Lett 21: 2264-9 (2011)
Article DOI: 10.1016/j.bmcl.2011.02.108
BindingDB Entry DOI: 10.7270/Q2MS3T23 |
More data for this
Ligand-Target Pair | |
RAF proto-oncogene serine/threonine-protein kinase
(Homo sapiens (Human)) | BDBM50340261
(7-(2-(3-(2-fluoro-5-(trifluoromethyl)phenyl)ureido...)Show SMILES CNC(=O)c1cc2ccc(CCNC(=O)Nc3cc(ccc3F)C(F)(F)F)cc2cn1 Show InChI InChI=1S/C21H18F4N4O2/c1-26-19(30)18-9-13-3-2-12(8-14(13)11-28-18)6-7-27-20(31)29-17-10-15(21(23,24)25)4-5-16(17)22/h2-5,8-11H,6-7H2,1H3,(H,26,30)(H2,27,29,31) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 250 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Serono
Curated by ChEMBL
| Assay Description
Inhibition of human cRAF using [gamma-33P-ATP] as a substrate by scintillation counting |
Bioorg Med Chem Lett 21: 2264-9 (2011)
Article DOI: 10.1016/j.bmcl.2011.02.108
BindingDB Entry DOI: 10.7270/Q2MS3T23 |
More data for this
Ligand-Target Pair | |
RAF proto-oncogene serine/threonine-protein kinase
(Homo sapiens (Human)) | BDBM50340284
(CHEMBL1760735 | N-(6-(2-(3-(2-(2-aminoethoxy)-5-(t...)Show SMILES CC(=O)Nc1nc2ccc(CCNC(=O)Nc3cc(ccc3OCCN)C(F)(F)F)cc2[nH]1 Show InChI InChI=1S/C21H23F3N6O3/c1-12(31)27-19-28-15-4-2-13(10-16(15)29-19)6-8-26-20(32)30-17-11-14(21(22,23)24)3-5-18(17)33-9-7-25/h2-5,10-11H,6-9,25H2,1H3,(H2,26,30,32)(H2,27,28,29,31) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 250 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Serono
Curated by ChEMBL
| Assay Description
Inhibition of human cRAF using [gamma-33P-ATP] as a substrate by scintillation counting |
Bioorg Med Chem Lett 21: 2264-9 (2011)
Article DOI: 10.1016/j.bmcl.2011.02.108
BindingDB Entry DOI: 10.7270/Q2MS3T23 |
More data for this
Ligand-Target Pair | |
RAF proto-oncogene serine/threonine-protein kinase
(Homo sapiens (Human)) | BDBM50340287
(CHEMBL1760616 | N-methyl-7-(2-(3-(3-(trifluorometh...)Show SMILES CNC(=O)c1cc2ccc(CCNC(=O)Nc3cccc(OC(F)(F)F)c3)cc2cn1 Show InChI InChI=1S/C21H19F3N4O3/c1-25-19(29)18-10-14-6-5-13(9-15(14)12-27-18)7-8-26-20(30)28-16-3-2-4-17(11-16)31-21(22,23)24/h2-6,9-12H,7-8H2,1H3,(H,25,29)(H2,26,28,30) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
| Article
PubMed
| n/a | n/a | 260 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Serono
Curated by ChEMBL
| Assay Description
Inhibition of human cRAF using [gamma-33P-ATP] as a substrate by scintillation counting |
Bioorg Med Chem Lett 21: 2264-9 (2011)
Article DOI: 10.1016/j.bmcl.2011.02.108
BindingDB Entry DOI: 10.7270/Q2MS3T23 |
More data for this
Ligand-Target Pair | |
RAF proto-oncogene serine/threonine-protein kinase
(Homo sapiens (Human)) | BDBM50340271
(6-(2-(3-(4-chloro-3-(trifluoromethyl)phenyl)ureido...)Show SMILES CNC(=O)c1nc2ccc(CCNC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2[nH]1 Show InChI InChI=1S/C19H17ClF3N5O2/c1-24-17(29)16-27-14-5-2-10(8-15(14)28-16)6-7-25-18(30)26-11-3-4-13(20)12(9-11)19(21,22)23/h2-5,8-9H,6-7H2,1H3,(H,24,29)(H,27,28)(H2,25,26,30) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
| Article
PubMed
| n/a | n/a | 280 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Serono
Curated by ChEMBL
| Assay Description
Inhibition of human cRAF using [gamma-33P-ATP] as a substrate by scintillation counting |
Bioorg Med Chem Lett 21: 2264-9 (2011)
Article DOI: 10.1016/j.bmcl.2011.02.108
BindingDB Entry DOI: 10.7270/Q2MS3T23 |
More data for this
Ligand-Target Pair | |
RAF proto-oncogene serine/threonine-protein kinase
(Homo sapiens (Human)) | BDBM50340278
(CHEMBL1760638 | N-(6-(2-(3-(4-chloro-2-methoxy-5-m...)Show SMILES COc1cc(Cl)c(C)cc1NC(=O)NCCc1ccc2nc(NC(C)=O)[nH]c2c1 Show InChI InChI=1S/C20H22ClN5O3/c1-11-8-17(18(29-3)10-14(11)21)26-20(28)22-7-6-13-4-5-15-16(9-13)25-19(24-15)23-12(2)27/h4-5,8-10H,6-7H2,1-3H3,(H2,22,26,28)(H2,23,24,25,27) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 320 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Serono
Curated by ChEMBL
| Assay Description
Inhibition of human cRAF using [gamma-33P-ATP] as a substrate by scintillation counting |
Bioorg Med Chem Lett 21: 2264-9 (2011)
Article DOI: 10.1016/j.bmcl.2011.02.108
BindingDB Entry DOI: 10.7270/Q2MS3T23 |
More data for this
Ligand-Target Pair | |
RAF proto-oncogene serine/threonine-protein kinase
(Homo sapiens (Human)) | BDBM50340268
(6-(2-(3-(2-methoxy-5-(trifluoromethyl)phenyl)ureid...)Show SMILES CNC(=O)c1nc2ccc(CCNC(=O)Nc3cc(ccc3OC)C(F)(F)F)cc2[nH]1 Show InChI InChI=1S/C20H20F3N5O3/c1-24-18(29)17-26-13-5-3-11(9-14(13)27-17)7-8-25-19(30)28-15-10-12(20(21,22)23)4-6-16(15)31-2/h3-6,9-10H,7-8H2,1-2H3,(H,24,29)(H,26,27)(H2,25,28,30) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
| Article
PubMed
| n/a | n/a | 340 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Serono
Curated by ChEMBL
| Assay Description
Inhibition of human cRAF using [gamma-33P-ATP] as a substrate by scintillation counting |
Bioorg Med Chem Lett 21: 2264-9 (2011)
Article DOI: 10.1016/j.bmcl.2011.02.108
BindingDB Entry DOI: 10.7270/Q2MS3T23 |
More data for this
Ligand-Target Pair | |
RAF proto-oncogene serine/threonine-protein kinase
(Homo sapiens (Human)) | BDBM50340267
(7-(2-(3-(4-chloro-2-(2-(dimethylamino)ethoxy)-5-(t...)Show SMILES CNC(=O)c1cc2ccc(CCNC(=O)Nc3cc(c(Cl)cc3OCCN(C)C)C(F)(F)F)cc2cn1 Show InChI InChI=1S/C25H27ClF3N5O3/c1-30-23(35)21-11-16-5-4-15(10-17(16)14-32-21)6-7-31-24(36)33-20-12-18(25(27,28)29)19(26)13-22(20)37-9-8-34(2)3/h4-5,10-14H,6-9H2,1-3H3,(H,30,35)(H2,31,33,36) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 340 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Serono
Curated by ChEMBL
| Assay Description
Inhibition of human cRAF using [gamma-33P-ATP] as a substrate by scintillation counting |
Bioorg Med Chem Lett 21: 2264-9 (2011)
Article DOI: 10.1016/j.bmcl.2011.02.108
BindingDB Entry DOI: 10.7270/Q2MS3T23 |
More data for this
Ligand-Target Pair | |
RAF proto-oncogene serine/threonine-protein kinase
(Homo sapiens (Human)) | BDBM50340286
(CHEMBL1760615 | N-methyl-7-(2-(3-(3-(trifluorometh...)Show SMILES CNC(=O)c1cc2ccc(CCNC(=O)Nc3cccc(c3)C(F)(F)F)cc2cn1 Show InChI InChI=1S/C21H19F3N4O2/c1-25-19(29)18-10-14-6-5-13(9-15(14)12-27-18)7-8-26-20(30)28-17-4-2-3-16(11-17)21(22,23)24/h2-6,9-12H,7-8H2,1H3,(H,25,29)(H2,26,28,30) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 360 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Serono
Curated by ChEMBL
| Assay Description
Inhibition of human cRAF using [gamma-33P-ATP] as a substrate by scintillation counting |
Bioorg Med Chem Lett 21: 2264-9 (2011)
Article DOI: 10.1016/j.bmcl.2011.02.108
BindingDB Entry DOI: 10.7270/Q2MS3T23 |
More data for this
Ligand-Target Pair | |
RAF proto-oncogene serine/threonine-protein kinase
(Homo sapiens (Human)) | BDBM50340289
(CHEMBL1760618 | N-methyl-7-(2-(3-(4-(trifluorometh...)Show SMILES CNC(=O)c1cc2ccc(CCNC(=O)Nc3ccc(cc3)C(F)(F)F)cc2cn1 Show InChI InChI=1S/C21H19F3N4O2/c1-25-19(29)18-11-14-3-2-13(10-15(14)12-27-18)8-9-26-20(30)28-17-6-4-16(5-7-17)21(22,23)24/h2-7,10-12H,8-9H2,1H3,(H,25,29)(H2,26,28,30) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 370 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Serono
Curated by ChEMBL
| Assay Description
Inhibition of human cRAF using [gamma-33P-ATP] as a substrate by scintillation counting |
Bioorg Med Chem Lett 21: 2264-9 (2011)
Article DOI: 10.1016/j.bmcl.2011.02.108
BindingDB Entry DOI: 10.7270/Q2MS3T23 |
More data for this
Ligand-Target Pair | |
RAF proto-oncogene serine/threonine-protein kinase
(Homo sapiens (Human)) | BDBM50340263
(7-(2-(3-(2-(2-(dimethylamino)ethoxy)-5-(trifluorom...)Show SMILES CNC(=O)c1cc2ccc(CCNC(=O)Nc3cc(ccc3OCCN(C)C)C(F)(F)F)cc2cn1 Show InChI InChI=1S/C25H28F3N5O3/c1-29-23(34)21-13-17-5-4-16(12-18(17)15-31-21)8-9-30-24(35)32-20-14-19(25(26,27)28)6-7-22(20)36-11-10-33(2)3/h4-7,12-15H,8-11H2,1-3H3,(H,29,34)(H2,30,32,35) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 450 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Serono
Curated by ChEMBL
| Assay Description
Inhibition of human cRAF using [gamma-33P-ATP] as a substrate by scintillation counting |
Bioorg Med Chem Lett 21: 2264-9 (2011)
Article DOI: 10.1016/j.bmcl.2011.02.108
BindingDB Entry DOI: 10.7270/Q2MS3T23 |
More data for this
Ligand-Target Pair | |
RAF proto-oncogene serine/threonine-protein kinase
(Homo sapiens (Human)) | BDBM50340274
(CHEMBL1760634 | N-(6-(2-(3-(3-(trifluoromethyl)phe...)Show SMILES CC(=O)Nc1nc2ccc(CCNC(=O)Nc3cccc(c3)C(F)(F)F)cc2[nH]1 Show InChI InChI=1S/C19H18F3N5O2/c1-11(28)24-17-26-15-6-5-12(9-16(15)27-17)7-8-23-18(29)25-14-4-2-3-13(10-14)19(20,21)22/h2-6,9-10H,7-8H2,1H3,(H2,23,25,29)(H2,24,26,27,28) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 480 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Serono
Curated by ChEMBL
| Assay Description
Inhibition of human cRAF using [gamma-33P-ATP] as a substrate by scintillation counting |
Bioorg Med Chem Lett 21: 2264-9 (2011)
Article DOI: 10.1016/j.bmcl.2011.02.108
BindingDB Entry DOI: 10.7270/Q2MS3T23 |
More data for this
Ligand-Target Pair | |
RAF proto-oncogene serine/threonine-protein kinase
(Homo sapiens (Human)) | BDBM50340275
(CHEMBL1760635 | N-(6-(2-(3-(3,4-dichlorophenyl)ure...)Show SMILES CC(=O)Nc1nc2ccc(CCNC(=O)Nc3ccc(Cl)c(Cl)c3)cc2[nH]1 Show InChI InChI=1S/C18H17Cl2N5O2/c1-10(26)22-17-24-15-5-2-11(8-16(15)25-17)6-7-21-18(27)23-12-3-4-13(19)14(20)9-12/h2-5,8-9H,6-7H2,1H3,(H2,21,23,27)(H2,22,24,25,26) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 480 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Serono
Curated by ChEMBL
| Assay Description
Inhibition of human cRAF using [gamma-33P-ATP] as a substrate by scintillation counting |
Bioorg Med Chem Lett 21: 2264-9 (2011)
Article DOI: 10.1016/j.bmcl.2011.02.108
BindingDB Entry DOI: 10.7270/Q2MS3T23 |
More data for this
Ligand-Target Pair | |
RAF proto-oncogene serine/threonine-protein kinase
(Homo sapiens (Human)) | BDBM50340280
(CHEMBL1760640 | N-(6-(2-(3-(4-chloro-5-methyl-2-(2...)Show SMILES CNCCOc1cc(Cl)c(C)cc1NC(=O)NCCc1ccc2nc(NC(C)=O)[nH]c2c1 Show InChI InChI=1S/C22H27ClN6O3/c1-13-10-19(20(12-16(13)23)32-9-8-24-3)29-22(31)25-7-6-15-4-5-17-18(11-15)28-21(27-17)26-14(2)30/h4-5,10-12,24H,6-9H2,1-3H3,(H2,25,29,31)(H2,26,27,28,30) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 490 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Serono
Curated by ChEMBL
| Assay Description
Inhibition of human cRAF using [gamma-33P-ATP] as a substrate by scintillation counting |
Bioorg Med Chem Lett 21: 2264-9 (2011)
Article DOI: 10.1016/j.bmcl.2011.02.108
BindingDB Entry DOI: 10.7270/Q2MS3T23 |
More data for this
Ligand-Target Pair | |
RAF proto-oncogene serine/threonine-protein kinase
(Homo sapiens (Human)) | BDBM50340276
(CHEMBL1760636 | N-(6-(2-(3-(3-chloro-4-methylpheny...)Show SMILES CC(=O)Nc1nc2ccc(CCNC(=O)Nc3ccc(C)c(Cl)c3)cc2[nH]1 Show InChI InChI=1S/C19H20ClN5O2/c1-11-3-5-14(10-15(11)20)23-19(27)21-8-7-13-4-6-16-17(9-13)25-18(24-16)22-12(2)26/h3-6,9-10H,7-8H2,1-2H3,(H2,21,23,27)(H2,22,24,25,26) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 530 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Serono
Curated by ChEMBL
| Assay Description
Inhibition of human cRAF using [gamma-33P-ATP] as a substrate by scintillation counting |
Bioorg Med Chem Lett 21: 2264-9 (2011)
Article DOI: 10.1016/j.bmcl.2011.02.108
BindingDB Entry DOI: 10.7270/Q2MS3T23 |
More data for this
Ligand-Target Pair | |
RAF proto-oncogene serine/threonine-protein kinase
(Homo sapiens (Human)) | BDBM50340283
(CHEMBL1760643 | N-(6-(2-(3-(2-(2-aminoethoxy)-4-ch...)Show SMILES CC(=O)Nc1nc2ccc(CCNC(=O)Nc3cc(C)c(Cl)cc3OCCN)cc2[nH]1 Show InChI InChI=1S/C21H25ClN6O3/c1-12-9-18(19(11-15(12)22)31-8-6-23)28-21(30)24-7-5-14-3-4-16-17(10-14)27-20(26-16)25-13(2)29/h3-4,9-11H,5-8,23H2,1-2H3,(H2,24,28,30)(H2,25,26,27,29) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Serono
Curated by ChEMBL
| Assay Description
Inhibition of human cRAF using [gamma-33P-ATP] as a substrate by scintillation counting |
Bioorg Med Chem Lett 21: 2264-9 (2011)
Article DOI: 10.1016/j.bmcl.2011.02.108
BindingDB Entry DOI: 10.7270/Q2MS3T23 |
More data for this
Ligand-Target Pair | |
RAF proto-oncogene serine/threonine-protein kinase
(Homo sapiens (Human)) | BDBM50340279
(CHEMBL1760639 | N-(6-(2-(3-(5-methyl-2-(2-(methyla...)Show SMILES CNCCOc1ccc(C)cc1NC(=O)NCCc1ccc2nc(NC(C)=O)[nH]c2c1 Show InChI InChI=1S/C22H28N6O3/c1-14-4-7-20(31-11-10-23-3)19(12-14)28-22(30)24-9-8-16-5-6-17-18(13-16)27-21(26-17)25-15(2)29/h4-7,12-13,23H,8-11H2,1-3H3,(H2,24,28,30)(H2,25,26,27,29) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 580 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Serono
Curated by ChEMBL
| Assay Description
Inhibition of human cRAF using [gamma-33P-ATP] as a substrate by scintillation counting |
Bioorg Med Chem Lett 21: 2264-9 (2011)
Article DOI: 10.1016/j.bmcl.2011.02.108
BindingDB Entry DOI: 10.7270/Q2MS3T23 |
More data for this
Ligand-Target Pair | |
RAF proto-oncogene serine/threonine-protein kinase
(Homo sapiens (Human)) | BDBM50340272
(CHEMBL1760632 | methyl 6-(2-(3-(4-chloro-3-(triflu...)Show SMILES COC(=O)Nc1nc2ccc(CCNC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2[nH]1 Show InChI InChI=1S/C19H17ClF3N5O3/c1-31-18(30)28-16-26-14-5-2-10(8-15(14)27-16)6-7-24-17(29)25-11-3-4-13(20)12(9-11)19(21,22)23/h2-5,8-9H,6-7H2,1H3,(H2,24,25,29)(H2,26,27,28,30) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 660 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Serono
Curated by ChEMBL
| Assay Description
Inhibition of human cRAF using [gamma-33P-ATP] as a substrate by scintillation counting |
Bioorg Med Chem Lett 21: 2264-9 (2011)
Article DOI: 10.1016/j.bmcl.2011.02.108
BindingDB Entry DOI: 10.7270/Q2MS3T23 |
More data for this
Ligand-Target Pair | |
RAF proto-oncogene serine/threonine-protein kinase
(Homo sapiens (Human)) | BDBM50340269
(CHEMBL1760629 | methyl 6-(2-(3-(2-methoxy-5-(trifl...)Show SMILES COC(=O)Nc1nc2ccc(CCNC(=O)Nc3cc(ccc3OC)C(F)(F)F)cc2[nH]1 Show InChI InChI=1S/C20H20F3N5O4/c1-31-16-6-4-12(20(21,22)23)10-15(16)27-18(29)24-8-7-11-3-5-13-14(9-11)26-17(25-13)28-19(30)32-2/h3-6,9-10H,7-8H2,1-2H3,(H2,24,27,29)(H2,25,26,28,30) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 810 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Serono
Curated by ChEMBL
| Assay Description
Inhibition of human cRAF using [gamma-33P-ATP] as a substrate by scintillation counting |
Bioorg Med Chem Lett 21: 2264-9 (2011)
Article DOI: 10.1016/j.bmcl.2011.02.108
BindingDB Entry DOI: 10.7270/Q2MS3T23 |
More data for this
Ligand-Target Pair | |
Search and Browse
